Transformation of myeloma into Ph1‐negative CML with plasma cell antigens

Elisabeth Paletta, Mervyn Goldstein, Peter Papenhausen, Niculae Ciobanu, Peter H. Wiernik

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


We report a patient in whom Ph1‐negative chronic myelogenous leukemia (CML) developed 15 years after the diagnosis of myeloma. Combined staining of morphologically myeloid elements in the peripheral blood for myeloid and plasmacytoid antigens revealed double‐marker expression, suggesting that the two neoplasms arose from a common originator cell.

Original languageEnglish (US)
Pages (from-to)289-292
Number of pages4
JournalAmerican Journal of Hematology
Issue number3
StatePublished - Jul 1985


  • chronic myelogenous leukemia
  • myeloma
  • shared antigen expression

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Transformation of myeloma into Ph1‐negative CML with plasma cell antigens'. Together they form a unique fingerprint.

Cite this